Opportunity ID: 323138

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AG-21-002
Funding Opportunity Title: Mechanisms of Rejuvenation and Age-Acceleration in Heterochronic Blood Exchange (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 17, 2019
Last Updated Date: Dec 17, 2019
Original Closing Date for Applications: Jun 17, 2020
Current Closing Date for Applications: Jun 17, 2020
Archive Date: Jul 23, 2020
Estimated Total Program Funding:
Award Ceiling: $300,000
Award Floor:

Eligibility

Eligible Applicants: State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Independent school districts
Native American tribal governments (Federally recognized)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
For profit organizations other than small businesses
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
Private institutions of higher education
Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This FOA will support research on aspects of rejuvenation and accelerated aging observed specifically in heterochronic blood exchange (HBE) experiments. The objectives are to identify the multiple factors involved, the multiple cell types involved and the mechanisms underlying rejuvenation or accelerated aging that is observed in the transfer of phenotypes between young and old laboratory animals. It is also anticipated that molecular signatures of rejuvenation or accelerated aging will be obtained from research supported under this FOA.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-002.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00257192 May 17, 2020 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00259158 May 17, 2020 Jun 17, 2020 View

Package 1

Mandatory forms

323138 RR_SF424_2_0-2.0.pdf

323138 PHS398_CoverPageSupplement_4_0-4.0.pdf

323138 RR_OtherProjectInfo_1_4-1.4.pdf

323138 PerformanceSite_2_0-2.0.pdf

323138 RR_KeyPersonExpanded_2_0-2.0.pdf

323138 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

323138 RR_Budget_1_4-1.4.pdf

323138 RR_SubawardBudget30_1_4-1.4.pdf

323138 PHS398_ModularBudget_1_2-1.2.pdf

323138 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

323138 RR_SF424_2_0-2.0.pdf

323138 PHS398_CoverPageSupplement_5_0-5.0.pdf

323138 RR_OtherProjectInfo_1_4-1.4.pdf

323138 PerformanceSite_2_0-2.0.pdf

323138 RR_KeyPersonExpanded_2_0-2.0.pdf

323138 PHS398_ResearchPlan_4_0-4.0.pdf

323138 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

323138 RR_Budget_1_4-1.4.pdf

323138 RR_SubawardBudget30_1_4-1.4.pdf

323138 PHS398_ModularBudget_1_2-1.2.pdf

323138 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T11:43:57-05:00

Share This Post, Choose Your Platform!

About the Author: